Notice2023-18449
Solicitation of Nominations for Appointment to the Lead Exposure and Prevention Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 28, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is soliciting nominations for membership on the Lead Exposure and Prevention Advisory Committee (LEPAC). The LEPAC is composed of 15 members that are Federal and non-Federal experts in fields associated with lead screening, the prevention of lead exposure, and services for individuals and communities affected by lead exposure.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 165 (Monday, August 28, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 165 (Monday, August 28, 2023)]
[Notices]
[Pages 58585-58586]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-18449]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Lead Exposure
and Prevention Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), is soliciting
nominations for membership on the Lead Exposure and Prevention Advisory
Committee (LEPAC). The LEPAC is composed of 15 members that are Federal
and non-Federal experts in fields associated with lead screening, the
prevention of lead exposure, and services for individuals and
communities affected by lead exposure.
DATES: Nominations for membership on the LEPAC must be received no
later than September 30, 2023. Packages received after this time will
not be considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to <a href="/cdn-cgi/l/email-protection#f3bfb6a3b2b0b3909790dd949c85"><span class="__cf_email__" data-cfemail="6c20293c2d2f2c0f080f420b031a">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H.,
Designated Federal Officer, National Center for Environmental Health,
Centers for Disease Control and Prevention, 4770 Buford Highway,
Atlanta, Georgia 30341. Telephone: 770-488-6774; Email:
<a href="/cdn-cgi/l/email-protection#3e6e7f52524951515a7e5d5a5d10595148"><span class="__cf_email__" data-cfemail="9fcfdef3f3e8f0f0fbdffcfbfcb1f8f0e9">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Nominations are being sought for
individuals with expertise in the fields of epidemiology, toxicology,
mental health, pediatrics, early childhood education, special
education, diet and nutrition, and environmental health. Members may be
invited to serve for three-year terms. Selection of members is based on
candidates' qualifications to contribute to the accomplishment of Lead
Exposure and Prevention Advisory Committee (LEPAC) objectives.
The members of this Committee are selected by the Secretary of the
Department of Health and Human Services (HHS). The committee's
objective is to advise the Secretary, HHS and the Director, Centers for
Disease Control and Prevention (CDC)/Administrator, Agency for Toxic
Substances and Disease Registry on a range of activities to include:
(1) review of Federal programs and services available to individuals
and communities exposed to lead; (2) review of the current research on
lead exposure to identify additional research needs; (3) review of and
identification of best practices, or the need for best practices
regarding lead screening and the prevention of lead exposure; (4)
identification of effective services, including services relating to
healthcare, education, and nutrition for individuals and communities
affected by lead exposure and lead poisoning, including in consultation
with, as appropriate, the lead exposure registry as established in
Public Law 114-322 section 2203(b) (42 U.S.C. 300j-27); and (5)
undertaking of any other review or activities that the Secretary
determines to be appropriate.
Annually as determined necessary by the Secretary or as required by
Congress, the committee shall submit a report to include: (1) an
evaluation of the effectiveness of the Federal programs and services
available to individuals and communities exposed to lead; (2) an
evaluation of additional lead exposure research needs; (3) an
assessment of any effective screening methods or best practices used or
developed to prevent or screen for lead exposure; (4) input and
recommendations for improved access to effective services relating to
health care, education, or nutrition for
[[Page 58586]]
individuals and communities impacted by lead exposure; and (5) any
other recommendations for communities affected by lead exposure, as
appropriate.
At least half of the committee will consist of Federal
representatives from a range of agencies that may include the
Department of Housing and Urban Development; the Environmental
Protection Agency; the Consumer Product Safety Commission; the Centers
for Medicare and Medicaid Services; the Health Resources and Services
Administration; the Food and Drug Administration (FDA); the U.S.
Department of Agriculture; the Occupational Safety and Health
Administration; the National Institute of Environmental Health
Sciences; the U.S. Geological Survey; and such additional Federal,
state, tribal, and local public and private officials as the Secretary
deems necessary for the committee to carry out its function. The rest
of the committee will consist of non-Federal members. Only non-Federal
members are being solicited with this announcement.
HHS policy stipulates that committee membership be balanced in
terms of points of view represented and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Current participation on Federal workgroups or prior
experience serving on a Federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning and annually
during their terms. CDC reviews potential candidates for LEPAC
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment as soon as the HHS selection process is
completed. Note that the need for different expertise varies from year
to year and a candidate who is not selected in one year may be
reconsidered in a subsequent year.
Candidates should submit the following items:
<bullet> Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
<bullet> At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (e.g., CDC, National Institutes of
Health, FDA).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-18449 Filed 8-25-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 28, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.